Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does thalidomide affect IL-2 response and production?

L P Fernandez1, P G Schlegel, J Baker

  • 1Bone Marrow Transplantation Program, Stanford University Medical Center, CA 94305, USA.

Experimental Hematology
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences of restrictive practices in child and adolescent mental health inpatient care: an integrative review.

Child and adolescent psychiatry and mental health·2026
Same author

1390 nm GaAs-based dilute nitride VCSELs on 150 mm wafers for scalable production.

Optics express·2026
Same author

Topographical memory in transient epileptic amnesia.

Epilepsy & behavior : E&B·2026
Same author

Co-production as the ultimate goal; an incentive or discouragement?

Research involvement and engagement·2025
Same author

Evidence of Genetic Isolation and Differentiation Among Historically Fragmented British Populations of Common Juniper, <i>Juniperus communis</i> L.

Ecology and evolution·2025
Same author

Author Correction: Electrical stimulation of smiling muscles reduces visual processing load and enhances happiness perception in neutral faces.

Communications psychology·2025
Same journal

Multidisciplinary Characterization of Rare MPL Y591 and R592 Variants in Myeloid Disorders: From Clinical Correlation and Literature-Based Evidence to In Silico Predictors and Structural Bioinformatics.

Experimental hematology·2026
Same journal

Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALL.

Experimental hematology·2026
Same journal

RNA Binding Protein PCBP1 Functions in the Endothelial-to-Hematopoietic Transition During Hematopoietic Stem Cell Formation.

Experimental hematology·2026
Same journal

Image-enabled cell sorting permits prospective isolation of primitive hematopoietic stem cell subsets with distinct functional potential.

Experimental hematology·2026
Same journal

Inhibition of MLLT1 Limits Growth of KMT2A::AFF1 Leukemias Without Killing Healthy Hematopoietic Stem Cells.

Experimental hematology·2026
Same journal

Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction.

Experimental hematology·2026
See all related articles

Thalidomide does not appear to suppress the immune response by affecting interleukin-2 (IL-2) production or IL-2 receptor activity in T lymphocytes. This study found no significant inhibition of IL-2 in Jurkat cells or proliferation in response to IL-2.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Thalidomide's immunosuppressive mechanisms remain unclear, despite its use in conditions like graft-vs.-host disease and autoimmune disorders.
  • T lymphocyte activation, leading to interleukin-2 (IL-2) synthesis and receptor expression, is a common pathway in these conditions.

Purpose of the Study:

  • To investigate the effect of thalidomide on interleukin-2 (IL-2) production in Jurkat cells.
  • To assess thalidomide's impact on IL-2 gene enhancer activity and IL-2-dependent cell proliferation.

Main Methods:

  • Utilized a reporter gene assay (beta-galactosidase) to measure IL-2 gene enhancer activity in thalidomide-treated Jurkat cells.
  • Quantified IL-2 production using an IL-2-dependent cell line (HT-2) and ELISA.

Related Experiment Videos

  • Assessed the effect of thalidomide on peripheral mononuclear cell proliferation.

    • Main Results:

    • Thalidomide did not inhibit IL-2 production or IL-2 gene enhancer activity in stimulated Jurkat cells across tested concentrations.
    • Cyclosporine demonstrated significant inhibition of IL-2 production, serving as a positive control.
    • Thalidomide did not inhibit IL-2-dependent proliferation of HT-2 cells or PHA-induced proliferation of peripheral mononuclear cells.

    Conclusions:

    • The findings do not support a modulatory effect of thalidomide on the immune response through the IL-2 pathway.
    • Thalidomide's immunosuppression likely operates via mechanisms independent of IL-2 production or response.